Subdural hematoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Fahimeh Shojaei (talk | contribs)
No edit summary
Fahimeh Shojaei (talk | contribs)
No edit summary
Line 34: Line 34:
*Type B Niemann–Pick disease
*Type B Niemann–Pick disease
== Associated Conditions ==
== Associated Conditions ==
Conditions associated with [disease name] include:
Conditions associated with subdural hematoma include:
* [Condition 1]
* Elderly
* [Condition 2]
* Anticoagulant use
* [Condition 3]
* Alcoholics
* Seizure
 
* CSF shunt
* Arachnoid cyst
 
* Meningioma
 
* Cocaine
* Dural metastase
* Roller coaster


== Gross Pathology ==
== Gross Pathology ==

Revision as of 14:48, 29 May 2019

Subdural Hematoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Subdural Hematoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subdural hematoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subdural hematoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subdural hematoma pathophysiology

CDC on Subdural hematoma pathophysiology

Subdural hematoma pathophysiology in the news

Blogs on Subdural hematoma pathophysiology

Directions to Hospitals Treating Subdural hematoma

Risk calculators and risk factors for Subdural hematoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

Physiology

The normal physiology of bridging veins can be understood as follows:[1]

  • In embryonic period, there is lots of anastomosis between brain and dura matter venous drainage.
  • After 12 weeks of gestation these anastomosis will disappear and what is left from them create bridging veins.
  • These vein s will drain venous blood from underlying brain tissue to the dural sinuses.
Bridging vein Source:Image Courtesy by Steven C. Gabaeff, MD


Pathogenesis

  • It is understood that subdural hematoma is the result of:
    • Rupture in bridging veins (mostly due to head trauma) and hemorrhage between dura matter and arachnoid, leading to subdural hematoma.
    • Rupture of small cortical atreries and hemorrhage into the space between dura matter and arachnoid, leading to subdural hematoma.
    • Intracranial hypotension (mostly due to lumbar punctue) and traction of bridging veins which leads to subdural hematoma
  • Subdural hematomas as a result of arterial rupture accounts for 20% of SDH cases and are mostly in temporoparietal region.
  • Since most of the SDH cases are due to vein rupture, the bleeding will stop on its own as a result of a clot formation or increased intracranial pressure.
https://commons.wikimedia.org/wiki/File:Types_of_Hematoma.jpg

Genetics

Genes involved in the pathogenesis of subdural hematoma include:

  • ADPKD[2][3][4][5][6]
  • Osteogenesis imperfecta
  • Fabry's disease
  • Mucopolysaccharidosis IIIB
  • Type B Niemann–Pick disease

Associated Conditions

Conditions associated with subdural hematoma include:

  • Elderly
  • Anticoagulant use
  • Alcoholics
  • Seizure
  • CSF shunt
  • Arachnoid cyst
  • Meningioma
  • Cocaine
  • Dural metastase
  • Roller coaster

Gross Pathology

On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Microscopic Pathology

On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].


References

  1. Famaey, Nele; Ying Cui, Zhao; Umuhire Musigazi, Grace; Ivens, Jan; Depreitere, Bart; Verbeken, Erik; Vander Sloten, Jos (2015). "Structural and mechanical characterisation of bridging veins: A review". Journal of the Mechanical Behavior of Biomedical Materials. 41: 222–240. doi:10.1016/j.jmbbm.2014.06.009. ISSN 1751-6161.
  2. McGovern, Margaret M.; Lippa, Natalie; Bagiella, Emilia; Schuchman, Edward H.; Desnick, Robert J.; Wasserstein, Melissa P. (2013). "Morbidity and mortality in type B Niemann–Pick disease". Genetics in Medicine. 15 (8): 618–623. doi:10.1038/gim.2013.4. ISSN 1098-3600.
  3. Pirson, Yves (2010). "Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease". Advances in Chronic Kidney Disease. 17 (2): 173–180. doi:10.1053/j.ackd.2010.01.003. ISSN 1548-5595.
  4. Mitsias, Panyiotis; Levine, Steven R. (1996). "Cerebrovascular complications of Fabry's disease". Annals of Neurology. 40 (1): 8–17. doi:10.1002/ana.410400105. ISSN 0364-5134.
  5. Groninger, Anja; Schaper, Jörg; Messing-Juenger, Martina; Mayatepek, Ertan; Rosenbaum, Thorsten (2005). "Subdural hematoma as clinical presentation of osteogenesis imperfecta". Pediatric Neurology. 32 (2): 140–142. doi:10.1016/j.pediatrneurol.2004.07.011. ISSN 0887-8994.
  6. Aydin M, Akarsu S, Kabakus N, Akpolat N (May 2006). "Mucopolysaccharidosis IIIB, cerebral vasculopathy and recurrent subdural hematoma". Indian Pediatr. 43 (5): 437–40. PMID 16735769.

Template:WH Template:WS